Creoptix AG

Creoptix develops and markets analytical instruments for drug discovery.Drugs work by binding to their drug target. To analyse this binding is therefore key for the pharmaceutical industry with an increasing need of higher sensitivity and the flexibility to measure a variety of samples. Based on proprietary and patented disruptive technology, Creoptix has launched and sells its first product, Creoptix WAVE, a system of instrument and disposables achieving unparalleled sensitivity in the market and offering measurements of even the most crude samples such as undiluted blood serum. This enables new applications in drug discovery but also in pharmacology and diagnostics.